Modulation of deoxycytidine kinase (dCK) and glycogen synthase kinase (GSK-3β) by anti-CD20 (rituximab) and 2-chlorodeoxyadenosine (2-CdA) in human lymphoid malignancies
Crossref DOI link: https://doi.org/10.1186/2162-3619-3-31
Published Online: 2014-12-19
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Al-Katib, Ayad M
Aboukameel, Amro
Ebrahim, AbdulShukkur
Beck, Frances WJ
Tekyi-Mensah, Samuel E
Raufi, Ali
Ahmed, Yasin
Mandziara, Mary
Kafri, Zyad
Article History
Received: 21 November 2014
Accepted: 22 November 2014
First Online: 19 December 2014